–
Corvus Pharmaceuticals, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
millions USD
FY21:
FY22:
–
FY23:
–
FY24:
–
FY25:
–
(positive)
Change from FY21 to FY25
millions USD
FY21:
−38.6
FY22:
−32.6
FY23:
−23.4
FY24:
−27.5
FY25:
−43.0
(positive)
Change from FY21 to FY25
millions USD
FY21:
−38.2
FY22:
−32.2
FY23:
−23.3
FY24:
5.91
FY25:
−70.0
(positive)
Change from FY21 to FY25
millions USD
FY21:
−43.2
FY22:
−41.3
FY23:
−21.7
FY24:
−59.1
FY25:
−13.3
(positive)
Change from FY21 to FY25
millions USD
FY21:
−43.2
FY22:
−41.3
FY23:
−27.0
FY24:
−62.3
FY25:
−15.3
All amounts in millions USD